Navigation Links
Biotage Launches New 24 Well Pyrosequencing(R) System
Date:3/31/2008

Next Generation Pyrosequencing(R) System; PyroMark(TM)Q24 Pyrosequencing

Technology in a 24 Well Format for Low Throughput Epigenetic Studies

UPPSALA, Sweden, March 31 /PRNewswire/ -- Pyrosequencing AB, a subsidiary of Biotage AB today announced the launch of PyroMark(TM)Q24 the latest in the range of Pyrosequencing(R) Systems. This new high-performance platform includes a complete software package for the study of genetic and epigenetic variation of genes, providing CpG methylation allele quantification and mutation analysis. These studies are used for a wide range of clinical research, for example the identification and tracking of changes involved in various forms of cancer. Studying these changes using Pyrosequencing(R) technology, which is based on the principals of sequencing by synthesis, is an ideal choice for genetic analysis in clinical research. The output information is based on real sequence data providing integrated quality control and security in the quality of the results.

The system, aimed at lower throughput needs, optimizes the management of fewer samples. The 24 well plate format and the ability to run and analyze both mutation and methylation assays on the same plate provides an ideal solution for managing low sample numbers or mixed analysis needs while providing the accuracy, flexibility and convenience offered by Pyrosequencing(R) technology.

Until now Pyrosequencing(R) technology has only been available in higher throughput systems, placing it out of the reach of many researchers. "With the introduction of the new PyroMark(TM)Q24 system we plan to open up the availability of Pyrosequencing(R) technology to many more researchers." Said Torben Jorgensen President and CEO of Biotage AB.

The PyroMark(TM)Q24 performance has been successfully demonstrated at sites in the US and Europe. Pyromark(TM)Q24 was shown to provide reproducible and reliable results at the Dept of Pathology, Uppsala University Hospital for clinical diagnostics in oncology.

According to Jakob Lindmark VP Sales and Marketing for Biosystems unit at Biotage the PyroMark(TM)Q24 is the first in a series of solutions for different applications in this lower throughput format.

About Biotage

Biotage is a global company active in life science research with strong technologies, a broad range of operations and a long-term view of the market. The company offers solutions, knowledge and experience in the areas of genetic analysis and medicinal chemistry. In 2005 operations and products were acquired from the American company Argonaut, further strengthening the medicinal chemistry product range. The customers include the world's top 30 pharmaceutical companies, the world's top 20 biotech companies, and leading academic institutes. The company is headquartered in Uppsala and has offices in the U.S., Japan, UK, Germany and several other European countries. Biotage has 336 employees and had sales of 496,4 MSEK in 2007. Biotage is listed on the OMX Nordic Exchange Stockholm AB. Website: http://www.biotage.com

Contact:

Jakob Lindmark

VP Sales and Marketing for Biosystems

Tel: +46-706-566022

Jakob.lindmark@eu.biotage.com

Biotage AB

Kungsgatan 76

SE-753 18 Uppsala

Tel: +46-18-56-59-00


'/>"/>
SOURCE Biotage AB
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Ferring Initial Purchase Order and Guaranteed Letter of Credit Launches Five Year Contract
2. Encision Launches Next Generation of EnTouch(R) Handles for Advanced Laparoscopic Procedures
3. Sagent Pharmaceuticals Launches Cefazolin for Injection, USP
4. BioElectronics Launches 1 Day Breast Augmentation Recovery Kit
5. Allen Institute for Brain Science Launches Three New Landmark Atlas Projects Focusing on the Human Brain, Developing Brain and Spinal Cord
6. Altogen Biosystems Launches Custom Biotechnology Research Services: Generation of Stable Cell Lines and RNAi Cell Transfection Services
7. Moleac Launches NeuroAid10(TM) in the United States
8. Genzyme Launches Renvela(R) in the U.S. for Dialysis Patients
9. MultiVu Video Feed: Johnson & Johnson Diabetes Institute, LLC Launches New Training Center to Improve Community-Based Diabetes Care
10. BioCrossroads Launches www.biocrossroadslinx.com and Releases Report on Biopharma Discovery and Development Contract Services
11. ChemAxon Launches Marvin and JChem Version 5: Better User Experience, Better Integration, More Flexibility and Higher Performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2017)... ... 2017 , ... Sonic Manufacturing Technologies is proud to be ... solar system on its roof top. “We will be independent of the grid ... stated. The company’s proud history of social responsibility and participation in the preservation ...
(Date:7/14/2017)... ... July 13, 2017 , ... ... verification test kit has received US FDA 510 (k) clearance for use on ... matrix, evaluates D-Dimer. Each VALIDATE® D-Dimer kit, prepared using the CLSI EP06-A “equal ...
(Date:7/13/2017)... ... ... Thousands of pilots from across the country will visit the AMA’s International ... to Muncie to compete in various categories of model flying competition. Each pilot comes ... championships. , RC Pylon (July 14-21): One of the most fun competitions to watch! ...
(Date:7/13/2017)... ... 2017 , ... In’Tech Medical SAS ( http://www.intech-medical.com ), the ... of a major transaction with Eurazeo PME. The reputable French private equity comes ... In’Tech Medical’s service offerings while leveraging the company’s manufacturing expertise and global footprint. ...
Breaking Biology Technology:
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market ... Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast ... from USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... , April 11, 2017 NXT-ID, ... security technology company, announces the appointment of independent Directors Mr. ... to its Board of Directors, furthering the company,s corporate ... ... NXT-ID, we look forward to their guidance and benefiting from ...
(Date:4/5/2017)... 2017 KEY FINDINGS The global ... a CAGR of 25.76% during the forecast period of ... factor for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is ... geography. The stem cell market of the product is ...
Breaking Biology News(10 mins):